DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Lipton A, Fizazi K, Stopeck AT et al.
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials.
Eur J Cancer 2012;
48: 3082-3092
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.